All-trans retinoic acid induces leukemic cells from patients with acute promyelocytic leukemia (M3) to differentiate in vitro to mature granulocytes which express the CDI 5 antigen and are capable of respiratory burst function. Of 3 5 M3 samples, only one failed to respond. In eight cases, we compared the efficacy of two naturally occurring isomers of retinoic acid, all-trans RA and 13-cis RA. Both isomers induce maximal differentiation at mol/L. The maximal DISEQUILIBRIUM between proliferation and differ-A entiation characterizes myeloid leukemic cells which appear blocked at a certain stage of their differentiation. This differentiation blockage is however sometimes reversible'? leukemic cells in agar or in liquid suspension culture show spontaneous differentiation3; they differentiate when incubated with various agents, and polymorphonuclear cells of some leukemic patients in complete remission have been shown by restriction fragment length polymorphism (RFLP) to arise from the leukemic clone.4 The study of leukemic cell differentiation has been greatly facilitated by establishment of leukemic cell lines that permits confirmation that the differentiated cells obtained originate from a leukemic progenitor. Retinoic acid (RA) is one of the most potent and extensively studied differentiating agents. It inhibits proliferation and induces differentiation of malignant cells in vitro., Various natural and synthetic retinoids have been studied for their effects on hematopoietic cells, namely on the human myeloblastic HL-60 leukemic cell All-trans-RA and 13-cis-RA, two isomers of RA, equally stimulate the growth of normal CFU-GM cells."," They have both been shown to inhibit the clonal cell growth of KG1 cells," and they both induce differentiation of U-937 cells with an EC,, of mol/L.I4 The proliferation of cells from patients with acute myeloid leukemia (AML) is either stimulated or inhibited in liquid" or methylcellulose c~l t u r e s . '~. '~ Leukemic cells from patients with acute promyelocytic leukemia (M3) differentiate in vitro in the presence of retinoids.'8'22 Because of their higher therapeutic indexes, the 13-cisisomer and the ethyl ester of Vitamin A have been most studied in clinical trials.23 The ethyl ester, which we found ineffective in vitro in the U-937 cell line,24 was also reported to be ineffective in v~vo.'~ Several reports have been published concerning the effect of 13-cis-RA in hematopoietic disorders characterized by bone marrow (BM) maturation abnormalities (myelodysplastic syndromes, MDS)26-28 or bone marrow maturation arrest (AML).29-33 Until recently, the compound used for RA treatment of acute leukemias was the 13-cis isomer. In M3 patients refractory to conventional chemotherapy, at a daily dose of 100 mg/m', it was beneficial in isolated case^.'^-'^ The original experience of Huang et aIz4 with all-trans RA in 24 M3 patients treated with a daily dose of 45 to 100 mg/m' per day alone or in association with cytotoxic drug is even more striking: 23 patients obtained complete remission, and intravascular disseminated coagulation either disappeared rapidly or was not observed after onset of treatment. Our own e~p e r i e n c e~~ with 22 M3 patients treated with all-trans R A alone corroborates the data of Huang et aLZ4
Because of their higher therapeutic indexes, the 13-cisisomer and the ethyl ester of Vitamin A have been most studied in clinical trials. 23 The ethyl ester, which we found ineffective in vitro in the U-937 cell line,24 was also reported to be ineffective in v~vo.'~ Several reports have been published concerning the effect of 13-cis-RA in hematopoietic disorders characterized by bone marrow (BM) maturation abnormalities (myelodysplastic syndromes, MDS)26-28 or bone marrow maturation arrest (AML).29-33 Until recently, the compound used for RA treatment of acute leukemias was the 13-cis isomer. In M3 patients refractory to conventional chemotherapy, at a daily dose of 100 mg/m', it was beneficial in isolated case^.'^-'^ The original experience of Huang et aIz4 with all-trans RA in 24 M3 patients treated with a daily dose of 45 to 100 mg/m' per day alone or in association with cytotoxic drug is even more striking: 23 patients obtained complete remission, and intravascular disseminated coagulation either disappeared rapidly or was not observed after onset of treatment. Our own e~p e r i e n c e~~ with 22 M3 patients treated with all-trans R A alone corroborates the data of Huang et aLZ4
We studied the in vitro effects of 13-cis RA and all-trans RA on leukemic cells from patients with M3. The effects of the two isomers on M3 cell differentiation are quantitatively different and suggest that in vitro data may correlate to in vivo efficacy. then removed by gentle pipetting and resuspended in culture medium; 95% of the samples had a leukemic cell fraction with more than 90% blasts.
MATERIALS AND METHODS
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Materials
All-trans RA, 1 3 4 s RA, and 4-oxo-all-trans RA, and 4-oxo-13-cis RA were provided by Dr Bollag, Hoffman-LaRoche (Basel, Switzerland). They were suspended in absolute ethanol at an initial stock concentration of lo-' mol/L and further diluted in RPMI 1640 medium. The final concentrations of ethanol in culture medium had no effect on cell growth or differentiation. All dilutions and cultures were performed in subdued light, and stock solutions were stored at -7OOC in foil-wrapped paper.
Cell Culture and Diflerentiation Assay
Leukemic cells were suspended in culture medium (RPMI 1640, 15% heat-inactivated FCS and antibiotics) at a concentration of IO6 cells/mL as re~ommended.'~ All cultures were incubated at 37OC in a 5% CO, humidified atmosphere for a minimum of 5 days in the presence of the different retinoids. Cell aliquots were taken at days 3 and 5 or later for assessment of viability and differentiation status. For each cell sample, a control was cultured in the same conditions in the absence of retinoids.
Survival and proliferation were assessed first by the trypan blue exclusion dye test: cell counts were made on a Malassez hemacytometer. When RBCs were present, the cell count was confirmed after an exclusion test with acetic blue. Second, survival and proliferation were assessed by incorporation of tritiated thymidine (3HTD): lo6 cells were collected at different intervals ( 1 hour and 24 and 72 hours or more), and aliquots of 2 x lo5 cells in triplicates were incubated in 96-well plates (Terasaki, Los Angeles, CA) with 1 pci (3.7 IO' Bq) 'H-TD (25 ci/mmol, 0.92 TBq/mmol specific activity, Amersham, UK). After 1-hour incubation at 37°C. cells were collected on filter paper with a cell harvester (Skatron, Lier, Norway), and radioactivity was counted and expressed as cpm/2 x lo5 cells. Inhibition of 'HTD incorporation after I-hour incubation with cytosine arabinoside Ara-C (Sigma, St Louis, MO) mol/L was also studied as a marker of multiplying cells." Differentiation was assessed on morphologic and functional criteria. Cytospin slide preparations were made from samples with or without RA. Slides werestained with May-GrunwaldGiemsa stain. Cells were categorized by standard morphologic criteria either as immature (blasts, promyelocytes, and promonocytes) or as mature (myelocyte stage and beyond). In most cases, a-naphtol acetate esterase-stained preparations were examined in parallel. The nitroblue tetrazolium (NBT) reduction test was performed using standard methodology with phorbol myristate acetate (PMA) as previously described." Differential counts were performed under light microscopy on a minimum of 200 cells. The percentage of cells containing intracellular reduced black formazan deposits was thus determined. Modulation of the expression of specific differentiation cell surface antigens was studied by monoclonal antibody (MoAb) binding with CD33 (MY9) and CD34 (MYIO) clusters from Coultronics, CD15 (Ig-IO) and CD14 (Leu M3) clusters from Becton Dickinson (Oxford, UK), and M075 polymorphonuclear antibody from Biomakor by indirect immunofluorescence. Cells (lo6) were incubated with the quantity of MoAb specified by the producer for 30 minutes at 4OC. After three washes, the cells were incubated 30 minutes more at 4OC in the dark in the presence of a second MoAb consisting of FITC-conjugated F (ab'), goat anti-mouse antiserum." The cells were washed three times. An aliquot was taken for preparation of slides and analysed on a fluorescence microscope (Zeiss, Oberkochen, FRG). The rest of the Cell culture.
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cells were resuspended in phosphate-buffered saline (PBS) with 1% paraformaldehyde and stored at 4OC in the dark until analysis on a cytofluorograph (Ortho SOH, Roissy, France, by R. Miglierina, Service Commun, Institut Hematologie). A logarithmic amplification allowed us to obtain reproducible percentages of fluorescein green fluorescence.
Statistical Analysis
Different measures of cell survival and differentiation status were analyzed: The effect of RA on cell concentration and cell viability was studied by comparing the cell concentration in the presence of RA at different times of incubation first to the initial cell concentration (R1 ratio) and second to the cell concentration in the control samples (R2 ratio). R1: viable cell concentration at day 3 or 5/viable cell concentration at day 0; R1-control day 3 or R1-control day 5 for the control samples and RI-RA day 3 or Rl-RA day 5 for RA-treated samples. R2: viable cell concentration in RA-treated samples/viable cell concentration in the control (R2-day 3 at day 3 and R2-day 5 at day 5 of incubation).
We considered a differentiated leukemic cell as a cell that had reached a stage of granulocytic maturation corresponding, cytologi- 
RESULTS
Eflect of All-Trans RA on AML3 Leukemic Cells mol/L on acute promyelocytic leukemic cells in suspension culture were studied in 35 samples of M3 patients. We wished to determine whether all-trans R A could stimulate terminal differentiation on fresh human M3 cells as in the human leukemic cell lines HL-60 and U-937.6373'0 Of these 35 M3 samples, all cases but one responded (Fig 1) . An
The effects of continuous exposure of all-trans R A extremely low percentage of cells spontaneously acquired the capacity to reduce NBT [ 1.3% k 2.7% (median 0%) at day 0; 3.5% k 5.6% (median 2%) at day 3; and 5% -t 6.3% (median 3%) at day 51. At day 3, in the presence of all-trans RA, more than 50% of the cells had the capacity to reduce NBT (64% k 24%, median 65%); this proportion reached 90% to 100% by day 5 (82.6% 18.9'36, median 90%). These results remained clearly significant when expressed as the total number of NBT-positive cells per milliliter. In three samples, a differentiation of the whole cell population was obtained only after 9 or 11 days of incubation.
Morphologically, the modifications of the promyelocytic leukemic cells during the differentiation induced by all-trans RA are variable from one sample to another, as the promyelocytic leukemic cells often are before treatment. After 5-day incubation with RA, however, all leukemic cells have a For maturation between nucleus and cytoplasm as the persistence of Auer rods confirms that the differentiated cell originates from the M3 cells. (Fig 2A and B) . There was a substantial increase in the expression of the CD15 granulocytic differentiation antigen, recognized by the IglO MoAb ( Table 1) . As compared with the control samples, RAtreated cells showed a decrease or absence of self-renewal and reduction of 'H-Td incorporation in six samples tested (78% + 17%) (Fig 3) .
Throughout the in vitro culture period, no modification of cell concentration occurred (Rl-control day 3, 0.84 * 0.3;
Rl-RA day 3, 0.98 f 0.3, R1-control day 5,0.92 + 0.5, and
Rl-RA day 5, 1.0 f 0.7). A trend in the increase of cell concentration in the RA-treated samples was noted, however. As compared with the initial cell concentration (Rl-RA), 10 cases had a ratio greater than 1.1 ( Table 2) . No decrease in the percentage of differentiated cells was observed. Six of these cases had an increased ratio of the control (Rl-C), which could reflect variation in the initial cell concentration at day 0. That the number of cells in the presence of RA was correlated to the control cell concentration of the same day ( r = 0.82, P < .001 at day 3; and r = 0.80, P < .001 at day 5) and remained superior to the control (R2-RA ratio >1.1) in 15 cases, however, may suggest that R A plays a part in the proliferation and survival of some M3 leukemic clones.
Structure-Dose Effect of Retinoids in AML3 Leukemic Cells
The effect of different concentrations of the two isomers, all-trans RA and 1 3 4 s RA was tested in eight different M3 cases. The possibility of inducing terminal differentiation was dose dependent between lo-' and mol/L, both isomers were equally effective in inducing NBT reduction. At lo-' mol/L, however, a maximal effect was already achieved in all cases with all-trans RA and in only three cases with 1 3 4 s RA ( P < ,001; sign test). At IO-* mol/L. At mol/L, the effect of 13-cis RA was not detectable, whereas in certain cases a differentiation was already apparent with all-trans RA (Fig 4A) . The number of viable cells after 3-and 5-day incubation with either isomer was variable and not significantly different whatever the concentration and differentiation effect obtained. There was no difference in cell viability between the two isomers at the concentrations used (Fig 4B) .
Effect of All Trans-RA on Acute Myeloid Leukemic Cells in Short-Term Culture
To determine if the biologic effects of all-trans RA described above were specific to M3 leukemic cells, we studied 36 samples of randomly selected AML patients.
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Fourteen cases acquired cytologic and functional features of terminally differentiated granulocytic cells: two of the 13 M 1 cases, two of the 8 M2 cases, and 10 of the 10 M3 cases (Fig  5) . The magnitude of the response in the M 3 subtype was significantly higher than in the other groups, even when the nonresponders were excluded (P < .001, Mann-Whitney U test). In the absence or presence of RA, only seven cases (18%) showed a cell concentration (Rl-C or Rl-RA) ratio > 1.1 .Thirteen cases had a cell concentration in R A samples superior to the control of the same day (R2-day 5 > 1.1): 6 of the 13 M1, 1 of the 8 M 2 , 3 of the 10 M 3 , l of the 3 M4, and 2 of the M5. Determination of the inhibition of 'H-TD incorporation after 1 -hour incubation with Ara-C, allowed estimation of the proportion of multiplying cells. Of the different ANLL cell types, only the samples of the M3 group who had a R2-day 5 ratio > 1.1 were highly correlated to the inhibition of 3H-TD incorporation with Ara-C P -= .01 (all samples showing >70% inhibition). There was no correlation between all-trans R A effect on proliferation and differentiation on these different myeloid leukemic clones.
DISCUSSION
We compared the effects of two isomers of RA, all-trans and 13-cis, on the blast cells of patients with acute promyelocytic leukemia. First, this study confirms that the most studied isomer, all-trans RA, at a concentration of mol/L, induces a specific and consistent differentiating effect in M3 cells. In 36 randomly studied cases of ANLL, all 10 M3 samples responded to all-trans R A and only four of other AML subtypes (two M1 and two M2). On 35 other M3 sequential samples, all cases but one responded (a case having cytogenetic characteristics of M 3 cells).34 These cells rapidly acquire the function of respiratory burst and cytologically reach the stage of metamyelocytes and band cells. Differentiation surface antigens specific of the polymorphonuclear stage were not expressed after 5 days in culture with RA, however, which could mean either that under such a short incubation time synthesis of certain differentiation antigens was not achieved or that this anomaly was characteristic of the differentiated leukemic cell. Only the CD 15 antigen was significantly increased, as already reported by Findley et a1 in three cases of childhood M3. '8.39 In this model of suspension culture, there was an increase in cell number a t day 5 in the presence of R A in half of the samples. In these cases, the differentiation response did not differ from the other cases. Because cell number in the presence of R A correlated to the cell number of the control, these data suggest that R A may play a role in the proliferation and survival of certain leukemic clones in vitro. Of the four patients who had a hyperleukocytosis with all-trans R A the rap^,'^ three are in the group of patients with at least one index cell concentration ratio greater than 1.1. These results are too preliminary, however, and the number of cases too small to allow a correlation between in vitro and in vivo proliferation. No leukemic cell culture on its own is a complete model in which to study in vitro leukemic cell proliferation. Studies on the effect of either isomer on clonogenicity and self-renewal of leukemic cells have been reported and show either inhibitory or stimulatory effects in ANLL sample^.'^.'^ In M3 samples, the data are limited. '6-'8 Our own data on M3 cases not included in this study are more in favor of an inhibitory effect on cell clonogenicity in the presence of RA.
This study also shows that the other isomer of RA, 13-cis RA, has an identical effect on M3 differentiation a t mol/L. The structure-dose studies performed in eight of the M3 cases of this study demonstrate, however, that a response of identical magnitude is obtained at mol/L with all-trans RA, as reported by Breitman et al in three M3 patient^,^ but the efficacy significantly decreases with 13-cis RA. Both drugs are ineffective at lo-' mol/L. At mol/L, differentiation is still observed. Cell viability was similar after 5-day incubation with both isomers, and cell concentration was not significantly different for concentrations greater than mol/L. The difference in activity therefore was not related to a difference in cell toxicity. The two metabolites, 4-oxo-13-cis and 4-oxo-all-trans ind-xed cell differentiation in M3 cells and had a structure-dose effect on M3 cells similar to that of the compound from which they originate.
This structure activity of the two isomers we observed in vitro was also confirmed by in vivo data. The efficacy of treatment of M3 cases with R A appears to be related to the dose and the compound given: Sampi et a1 reported no effect of the ethyl ester. 25 We noted no effect of 13-cis a t a dose of 45 mg/m2.40 At 100 mg/m2, efficacy of 13-cis was observed and complete remission was d~c u m e n t e d .~' .~~ That a relapse of the disease was observed when the dose of 13-cis R A was 
